Learning Objectives:

1. Participants should be able to identify the population of patients where extended aromatase inhibitor therapy may be beneficial.
2. Participants should be able to explain the potential side effects associated with aromatase inhibitor therapy.
3. Participants should be able to identify the various components of the geriatric assessment that are part of the ASCO guidelines for Geriatric Oncology.